Insights

Manufacturers

How to forge stronger working relationships with payers

Manufacturers

The essential guide to drug commercialization

Manufacturers

Six essential steps for emerging biopharma companies launching their first therapy

Manufacturers

Three questions biopharma companies must ask when building a cell and gene commercialization strategy

Manufacturers

Education: The centerpiece of biosimilar adoption

Manufacturers

New pan-EU HTA: How can biopharma navigate the joint clinical assessment?

Manufacturers

Webinar: Evaluate alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies

Manufacturers

Three questions to ask about your market access partner

Manufacturers

Acceleration of innovation in healthcare delivery

Manufacturers

Podcast: Conversations around interchangeability and biosimilar entries in new therapeutic categories

Manufacturers

Closing the gaps in pre-approval information exchange to accelerate product success and patient access

Manufacturers

Answering the challenges of rare disease market access with HEOR

Manufacturers

How will the Inflation Reduction Act affect the biopharma industry?

Manufacturers

Market access abroad: Three reasons why early planning is critical for HTA countries

Manufacturers

Podcast: Milestones for biosimilars in 2022 and looking ahead to 2023

Manufacturers

Innovative agreements: Exploring alternative payment models

Manufacturers

Why FormularyDecisions® is the right choice for enterprise biopharma payer engagement 

Manufacturers

Webinar slides: Navigating Reimbursement and Access Challenges for Novel Cell and Gene Therapies

Orphan drugs: trapped in the lock? A review of the lock system in the Netherlands

Manufacturers

Differentiate your product with FormularyDecisions®

Manufacturers

Six insights driving the evolution of FormularyDecisions®

Webinar: Debunking common PIE misperceptions to enhance your PIE strategy and tactics

Manufacturers

Essential skills for outsourced field solutions teams

Manufacturers

Building your field reimbursement and access team: The translational experience and skills that matter most

Manufacturers

eBook: Bringing innovation to market with digital therapeutics

Manufacturers

Navigating the payer landscape for digital therapeutics

Manufacturers

Patient support for digital therapeutics: Do's and don'ts for designing your program

Manufacturers

Work worth doing: Innovative field solutions

Manufacturers

Innomar Strategies: 20 years of innovative market access solutions

Manufacturers

Work worth doing: FormularyDecisions

Manufacturers

Podcast: ThinkLive Commercialization 2021

Manufacturers

On-demand webinar: Accelerating access to therapy (a view from the front lines)

Manufacturers

The hidden value of integrated commercialization services: A manufacturer’s perspective

Manufacturers

Ebook: Strategic partnerships for unlocking product potential

Manufacturers

The Value of Real-World Evidence in Canadian Drug Commercialization: Part 2

Manufacturers

How to make the most of integrated commercialization solutions

Manufacturers

Strategies for addressing copay accumulators: What manufacturers need to know

Manufacturers

Webinar: uptake or heartbreak with biosimilars? Progress and perspectives

Manufacturers

Pre-launch checklist: What to look for in a commercialization partner

Manufacturers

Checklist: Four things to look for in a field services partner

Manufacturers

Case study: an innovative field reimbursement program expands patient access

Manufacturers

Cell and gene therapies: bringing innovation to market

Manufacturers

Pharma in the field: Ashley's story

Manufacturers

Pharma in the field: Tierra's story

Manufacturers

Ebook: Virtual drug commercialization

Manufacturers

Is a contact-free clinical trial possible?

Patient support launch guide: novel therapies 

Manufacturers

Is your PIE incomplete?

Manufacturers

Rethink field services: Three myths keeping access barriers in front of your product

Manufacturers

Solving access, reimbursement, and PAP awareness problems

Manufacturers

Pharma in the field: Sales reps vs. reimbursement and access specialists

Manufacturers

The Future of Payer Engagement: How Pharma Can Break Through

Manufacturers

The Value of Virtual: How Remote Workshops Can Keep Market Access Efforts Moving

Manufacturers

Distant But Engaged: Transitioning to Virtual Training

Manufacturers

Mind the (Evidence) Gap

Manufacturers

InnomarLive 2019: Commercializing in Canada

Manufacturers

Biosimilars: Market Insights and Growth Factors

Manufacturers

Biosimilars: Launch Insights From the Field

Manufacturers

How Digital Innovation Drives Improved Market Access Strategies

Health Systems

Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part One

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part Two

Infographic: The Road to Commercialization in Canada

Manufacturers

What Do Payers Think About Digital Health Technologies

Manufacturers

The Route to Market Access in Canada